. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/therapeutic useCarcinoma, Squamous Cell/drug therapyCetuximabClinical Trials as TopicDrug ApprovalHead and Neck Neoplasms/drug therapyHumansUnited StatesUnited States Food and Drug Administration
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsCetuximab
Year: 2006 PMID: 16808060
Source DB: PubMed Journal: Cancer Biol Ther ISSN: 1538-4047 Impact factor: 4.742